CA2985396A1 - Cmlck gene transfer - Google Patents

Cmlck gene transfer

Info

Publication number
CA2985396A1
CA2985396A1 CA2985396A CA2985396A CA2985396A1 CA 2985396 A1 CA2985396 A1 CA 2985396A1 CA 2985396 A CA2985396 A CA 2985396A CA 2985396 A CA2985396 A CA 2985396A CA 2985396 A1 CA2985396 A1 CA 2985396A1
Authority
CA
Canada
Prior art keywords
cmlck
subject
seq
vector
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2985396A
Other languages
English (en)
French (fr)
Inventor
Mingdong Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zensun Shanghai Science and Technology Ltd
Original Assignee
Zensun Shanghai Science and Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zensun Shanghai Science and Technology Ltd filed Critical Zensun Shanghai Science and Technology Ltd
Publication of CA2985396A1 publication Critical patent/CA2985396A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11018—Myosin-light-chain kinase (2.7.11.18)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
CA2985396A 2015-05-08 2016-06-14 Cmlck gene transfer Abandoned CA2985396A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNCN201510232415.6 2015-05-08
CN201510232415.6A CN106177992A (zh) 2015-05-08 2015-05-08 cMLCK基因导入
PCT/CN2016/085699 WO2016180377A1 (zh) 2015-05-08 2016-06-14 cMLCK基因导入

Publications (1)

Publication Number Publication Date
CA2985396A1 true CA2985396A1 (en) 2016-11-17

Family

ID=57247711

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2985396A Abandoned CA2985396A1 (en) 2015-05-08 2016-06-14 Cmlck gene transfer

Country Status (10)

Country Link
US (1) US20180133291A1 (cg-RX-API-DMAC10.html)
EP (1) EP3295959A4 (cg-RX-API-DMAC10.html)
JP (1) JP2018515510A (cg-RX-API-DMAC10.html)
KR (1) KR20190008511A (cg-RX-API-DMAC10.html)
CN (3) CN111388682A (cg-RX-API-DMAC10.html)
AU (1) AU2016260473A1 (cg-RX-API-DMAC10.html)
BR (1) BR112017024065A2 (cg-RX-API-DMAC10.html)
CA (1) CA2985396A1 (cg-RX-API-DMAC10.html)
RU (1) RU2017142779A (cg-RX-API-DMAC10.html)
WO (1) WO2016180377A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
RU2650635C2 (ru) 2012-10-08 2018-04-16 Цзэньсунь (Шанхай) Сайенс Энд Текнолоджи, Ко., Лтд. Композиции и способы лечения сердечной недостаточности у пациентов с диабетом
CN111388682A (zh) * 2015-05-08 2020-07-10 上海泽生科技开发股份有限公司 cMLCK基因导入
CN115838437A (zh) * 2022-11-04 2023-03-24 广州达安基因股份有限公司 人NT-proBNP融合蛋白及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375185B2 (en) * 2000-09-12 2008-05-20 The United States Of America As Represented By The Department Of Health And Human Services Cardiac myosin light chain kinase polypeptide, encoding nucleic acid, and methods of use
US9580515B2 (en) * 2006-08-21 2017-02-28 Zensun (Shanghai) Science & Technology, Co., Ltd. Neukinase, a downstream protein of neuregulin
JP2009242388A (ja) * 2008-03-14 2009-10-22 National Cardiovascular Center 心臓特異的キナーゼの心不全診断および治療への応用
CN102416184A (zh) * 2011-12-08 2012-04-18 哈尔滨医科大学 microRNA-1的反义锁核苷酸序列在制备预防或治疗心肌梗死后心衰药物中的应用
CN111388682A (zh) * 2015-05-08 2020-07-10 上海泽生科技开发股份有限公司 cMLCK基因导入

Also Published As

Publication number Publication date
EP3295959A1 (en) 2018-03-21
RU2017142779A (ru) 2019-06-10
KR20190008511A (ko) 2019-01-24
JP2018515510A (ja) 2018-06-14
CN106177992A (zh) 2016-12-07
CN107735109A (zh) 2018-02-23
WO2016180377A1 (zh) 2016-11-17
AU2016260473A1 (en) 2017-12-21
CN111388682A (zh) 2020-07-10
RU2017142779A3 (cg-RX-API-DMAC10.html) 2019-12-03
US20180133291A1 (en) 2018-05-17
BR112017024065A2 (pt) 2018-08-07
EP3295959A4 (en) 2019-01-02

Similar Documents

Publication Publication Date Title
AU2004204815B2 (en) Method for in vivo regulation of cardiac muscle contractility
US10092628B2 (en) Treating cardiovascular or renal diseases
AU2007221470B2 (en) Phosphatase inhibitor Protein-1 as a regulator of cardiac function
US20180133291A1 (en) Cmlck gene transfer
CN112225793A (zh) 一种溶酶体靶向肽及其融合蛋白、携带融合蛋白编码序列的腺相关病毒载体及其应用
AU2022271265A1 (en) Compositions and methods for treating sensorineural hearing loss using stereocilin dual vector systems
US20250249126A1 (en) Plakophillin-2 gene therapy treatment methods
US20180099029A9 (en) Serca2 therapeutic compositions and methods of use
JP2022530168A (ja) 心臓保護的活性のあるタンパク質
CA3213231A1 (en) Gene therapy for arrhythmogenic right ventricular cardiomyopathy
KR20230035584A (ko) Dwarf 개방 판독 프레임을 위한 아데노-관련 바이러스 벡터
CN119233831A (zh) 用于与肌营养不良蛋白有关的心肌病的基因疗法组合物和治疗
US5776776A (en) DTEF-1 isoforms and uses thereof
US20230183320A1 (en) Recombinant fibcd1 and use therof in the treatment of muscle atrophy
WO2015153357A1 (en) Compositions and methods for improving cardiac function
WO2025235622A1 (en) Combinatorial gene therapy approaches
CA3185503A1 (en) Nrf2 activator for use in treating dilated cardiomyopathies
EA048503B1 (ru) Способы и композиции для генной терапии плакофиллином 2
HK1129392A (en) Phosphatase inhibitor protein-1 as a regulator of cardiac function
HK1083065B (en) Method for in vivo regulation of cardiac muscle contractility

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20220301